Argus lowered the firm’s price target on Iqvia (IQV) to $260 from $280 but keeps a Buy rating on the shares. The company delivered strong new-order growth in Q3, and looking ahead, the firm expects it to benefit from its sizable backlog and new technology offerings, the analyst tells investors in a research note. Based on Iqvia’s industry leadership, revenue visibility, recent contract wins, and history of technological innovation, Argus expects continued growth for the company in the coming quarters.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on IQV:
- Iqvia price target lowered to $265 from $280 at Morgan Stanley
- Iqvia price target lowered to $265 from $270 at Deutsche Bank
- Iqvia price target lowered to $255 from $270 at TD Cowen
- Iqvia price target lowered to $260 from $290 at BTIG
- Iqvia price target lowered to $223 from $256 at Baird
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
